827010

AstraZeneca Pharmaceuticals LP — FEI 2518137

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 12, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Wilmington, DE (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)